BDNF and Alzheimer disease: Several studies showed that the mRNA and protein expression levels of BDNF and its full-length receptor tropomyosin receptor kinase B (TrkB) are decreased in the hippocampus and neocortex of AD postmortem brains and in the substantia nigra of PD patients [7,79,80,81].